Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy

Characterization of the diverse malignant and stromal cell states that make up soft tissue sarcomas and their correlation with patient outcomes has proven difficult using fixed clinical specimens. Here, we employed EcoTyper, a machine-learning framework, to identify the fundamental cell states and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature cancer 2024-03, Vol.5 (4), p.642-658
Hauptverfasser: Subramanian, Ajay, Nemat-Gorgani, Neda, Ellis-Caleo, Timothy J, van IJzendoorn, David G P, Sears, Timothy J, Somani, Anish, Luca, Bogdan A, Zhou, Maggie Y, Bradic, Martina, Torres, Ileana A, Oladipo, Eniola, New, Christin, Kenney, Deborah E, Avedian, Raffi S, Steffner, Robert J, Binkley, Michael S, Mohler, David G, Tap, William D, D'Angelo, Sandra P, van de Rijn, Matt, Ganjoo, Kristen N, Bui, Nam Q, Charville, Gregory W, Newman, Aaron M, Moding, Everett J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Characterization of the diverse malignant and stromal cell states that make up soft tissue sarcomas and their correlation with patient outcomes has proven difficult using fixed clinical specimens. Here, we employed EcoTyper, a machine-learning framework, to identify the fundamental cell states and cellular ecosystems that make up sarcomas on a large scale using bulk transcriptomes with clinical annotations. We identified and validated 23 sarcoma-specific, transcriptionally defined cell states, many of which were highly prognostic of patient outcomes across independent datasets. We discovered three conserved cellular communities or ecotypes associated with underlying genomic alterations and distinct clinical outcomes. We show that one ecotype defined by tumor-associated macrophages and epithelial-like malignant cells predicts response to immune-checkpoint inhibition but not chemotherapy and validate our findings in an independent cohort. Our results may enable identification of patients with soft tissue sarcomas who could benefit from immunotherapy and help develop new therapeutic strategies.
ISSN:2662-1347
2662-1347
DOI:10.1038/s43018-024-00743-y